IP Library Granted Patent US 9,845,283
Granted Patent B2
US 9,845,283 · App. 15/232,599 · Granted Dec 19, 2017

Methods of producing cancer targeting compounds

Inventors: John K Lynch (Cedarburg, WI); Jeff Hutchison (Sheboygan, WI); Xiong Fu (Superior, CO); Kevin Kunnen (Plymouth, IN)
Assignee: INSPYR THERAPEUTICS, INC.
C07C227/16A61K31/365A61K47/48246C07C227/02C07C227/18C07C229/08C07C269/04C07C269/06C07C271/22C07D307/93C07K5/06104C07K5/06113
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,845,283
App. No.
15/232,599
Granted
Dec 19, 2017
Kind
B2
Abstract

Provided herein are methods of making the compound of Formula I: and certain intermediates involved in such process.

Claims (29)

1. A method of producing 12-ADT, having Formula 6

the method comprising

(a) reacting thapsigargin, having Formula 2

 to produce 8-O-debutanoyl-thapsigargin, having Formula 3

(b) reacting 8-O-debutanoyl-thapsigargin (3) with Boc-12-AD, having Formula 4

 to produce Boc-12ADT, having Formula 5

 and

(c) deprotecting Boc-12ADT (5) to produce 12-ADT (6).

2. The method of claim 1 , wherein, in (a), thapsigargin (2) is reacted with sodium ethoxide in ethanol.

3. The method of claim 2 , wherein the reaction in (a) is at a temperature of −15±5° C.

4. The method of claim 1 , wherein, in (b), 8-O-debutanoyl-thapsigargin (3) is reacted with Boc-12-AD (4) in the presence of 4-dimethylaminopyridine and dichloromethane until a homogeneous solution is obtained, after which diisopropylcarbodiimide is added.

5. The method of claim 1 , wherein, in (c), Boc-12ADT (5) is dissolved in dichloromethane and deprotected with trifluoroacetic acid.

6. The method of claim 1 , wherein

in (a), thapsigargin (2) is reacted with sodium ethoxide in ethanol at a temperature of −15±5° C.;

in (b), 8-O-debutanoyl-thapsigargin (3) is reacted with Boc-12-AD (4) in the presence of 4-dimethylaminopyridine and dichloromethane until a homogeneous solution is obtained, after which diisopropylcarbodiimide is added; and

in (c), Boc-12ADT (5) is dissolved in dichloromethane and deprotected with trifluoroacetic acid.

7. The method of claim 1 , wherein Boc-12-AD (4) is produced by a method comprising

esterify, by acid catalysis in methanol, 12-AD, having Formula 10

 to form the compound of Formula 11

react the compound of formula 11 with Boc 2 O to form the compound of Formula

 and

hydrolyze the compound of Formula 12 to form the compound of Formula 4.

8. The method of claim 7 , wherein the acid catalysis of the compound of Formula 10 is with acetyl chloride.

9. The method of claim 7 , wherein the reaction with Boc 2 O with the compound of Formula 11 is in CH 2 Cl 2 in the presence of dimethylaminopyridine and triethylamine.

10. The method of claim 7 , wherein the compound of Formula 12 is hydrolyzed with NaOH.

11. The method of claim 7 , wherein

the acid catalysis of the compound of Formula 10 is with acetyl chloride;

the reaction with Boc 2 O with the compound of Formula 11 is in CH 2 Cl 2 in the presence of dimethylaminopyridine and triethylamine; and

the compound of Formula 12 is hydrolyzed with NaOH.

Assignments (2)
CHANGE OF NAME Recorded Oct 13, 2016
From: GENSPERA, INC.
To: INSPYR THERAPEUTICS, INC.
Reel/Frame 040350/0234 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2016
From: LYNCH, JOHN K; HUTCHISON, JEFF; FU, XIONG; KUNNEN, KEVIN
To: GENSPERA, INC.
Reel/Frame 039850/0281 →
Continuity (3)
Division 14776730
Provisional Application 61791909 · Mar 15, 2013
Related Publication 20160347730A1 · Dec 1, 2016